REQUEST A DEMO
Total
USD $0.00
Search more companies

Xbiolab Sp. z o.o. (Poland)

Main Activities: Scientific Research and Development Services
Secondary Activities: Synthetic Dye and Pigment Manufacturing | Other Basic Inorganic Chemical Manufacturing | Other Basic Organic Chemical Manufacturing | Pharmaceutical Preparation Manufacturing | Soap and Other Detergent Manufacturing | Toilet Preparation Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Xbiolab Sp. z o.o. Profile Updated: June 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Xbiolab Sp. z o.o. is a company in Poland, with a head office in Pulawy. It operates in the Scientific Research and Development Services sector. The company was established on February 23, 2021. A growth of 5.01% was recorded in its total assets.

Headquarters
Ul. Ignacego Moscickiego 1
Pulawy; Lubelskie; Postal Code: 24-110

Contact Details: Purchase the Xbiolab Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Xbiolab Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Xbiolab Sp. z o.o. report to view the information.
Incorporation Date:
February 23, 2021
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Xbiolab Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total assets
5.01%
Total equity
-21.79%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?